This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Innate Pharma. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Stéphanie Zerbib: Innovator in Cancer Treatment
Introduction
Stéphanie Zerbib is a prominent inventor based in Marseilles, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of binding agents.
Latest Patents
Stéphanie holds 2 patents related to KIR3DL2 binding agents. Her inventions focus on methods for treating cancer and inflammatory diseases using antibodies, including monoclonal antibodies, antibody fragments, and their derivatives that specifically bind to KIR3DL2. These patents also encompass the production of antibodies, their fragments, variants, and derivatives, as well as pharmaceutical compositions that include these innovative agents.
Career Highlights
Stéphanie is currently associated with Innate Pharma, a company dedicated to developing innovative immunotherapies for cancer treatment. Her work has positioned her as a key figure in the advancement of therapeutic strategies aimed at combating cancer.
Collaborations
Throughout her career, Stéphanie has collaborated with notable colleagues, including Laurent Gauthier and Simon Kollnberger. These partnerships have further enhanced her research and development efforts in the field of cancer treatment.
Conclusion
Stéphanie Zerbib's contributions to cancer treatment through her innovative patents and collaborations highlight her role as a leading inventor in the medical field. Her work continues to pave the way for advancements in therapeutic approaches to combat cancer and inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile